Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
Sadda
Srinivas R
SR
Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. sadda@usc.edu
Stoller
Glenn
G
Boyer
David S
DS
Blodi
Barbara A
BA
Shapiro
Howard
H
Ianchulev
Tsontcho
T